Current Pharmacogenomics and Personalized Medicine
Title:Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?
Volume: 10 Issue: 3
Author(s): Christopher Reist, Jogeshwar Mukherjee and Joseph C. Wu
Affiliation:
Keywords: Antipsychotic, Blood-brain-barrier, Dopamine receptor, Neuroimaging, P-glycoprotein, Pituitary.
Export Options
About this article
Cite this article as:
Reist Christopher, Mukherjee Jogeshwar and C. Wu Joseph, Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?, Current Pharmacogenomics and Personalized Medicine 2012; 10 (3) . https://dx.doi.org/10.2174/187569212802509979
DOI https://dx.doi.org/10.2174/187569212802509979 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypoxic Preconditioning Ameliorates Amyloid-β Pathology and Longterm Cognitive Decline in AβPP/PS1 Transgenic Mice
Current Alzheimer Research Editorial [Hot topic: G-Protein Coupled Receptors: Drug Targets of Key Importance (Guest Editors: Luca Piali and Christoph Boss)]
Current Topics in Medicinal Chemistry Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges
Current Medicinal Chemistry Human Disease and Drug Pharmacology, Complex as Real Life
Current Medicinal Chemistry Depression in Older Persons with Mobility Limitations
Current Pharmaceutical Design Pharmacology of Cyclic Peptides: Vancomycin and Oxytocin as Paradigms
Protein & Peptide Letters 5-HT1 Receptors
Current Drug Targets - CNS & Neurological Disorders Calcium Channel Blockers in Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Antiplatelet Drug Target in Atherosclerotic Diseases
Cardiovascular & Hematological Disorders-Drug Targets Can Life Before Birth Affect Health Ever After?
Current Women`s Health Reviews G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More
Current Pharmaceutical Biotechnology Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain Management
Current Neuropharmacology Cystatin C in Cerebrovascular Disorders
Current Neurovascular Research Involvement of Potassium and Chloride Channels and Other Transporters in Volume Regulation by Spermatozoa
Current Pharmaceutical Design Mild Cognitive Impairment: Advantages of a Comprehensive Neuropsychological Assessment
Current Alzheimer Research Peptides for Therapy and Diagnosis of Alzheimer's Disease
Current Pharmaceutical Design Mesenchymal Stem Cell Therapy in Intracerebral Haemorrhagic Stroke
Current Medicinal Chemistry Interleukin-1β Plays a Role in the Activation of Peripheral Leukocytes after Blood-Brain Barrier Rupture in the Course of Subarachnoid Hemorrhage
Current Neurovascular Research Neuroimagenomics for the Study of Human Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)